The Senate committee on Health, Education, Labor and Pensions (HELP) voted the FDA Device Accountability Act of 2015 (S. 1622), along with six other health care-related bills, out of committee at a Feb. 9 executive session. Bipartisan comity was on display for most of the hearing, although one piece of legislation seems destined to stir up yet more controversy on Capitol Hill.